Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration

Published:2020-03 Issue:12 Volume:75 Page:1386-1402
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Mendieta Guiomar,Ben-Aicha Soumaya,Gutiérrez Manuel,Casani Laura,Aržanauskaitė Monika,Carreras Francesc,Sabate Manel,Badimon Lina,Vilahur Gemma

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

2. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N Engl J Med,2004

3. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) randomized trial;Di Sciascio;J Am Coll Cardiol,2009

4. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation;Ibanez;Eur Heart J,2018

5. [2016 ESC/EAS guidelines for the management of dyslipidaemias];Catapano;Kardiol Pol,2016

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac adverse events associated with statins in myocardial infarction patients: a pharmacovigilance analysis of the FDA Adverse Event Reporting System;2024-08-16

2. In-hospital cardiac arrest after STEMI: prevention strategies and post-arrest care;Expert Review of Cardiovascular Therapy;2024-07-30

3. Effect of Shenfu Injection on Myocardial Injury After Primary PCI for STEMI: The RESTORE Trial;2024-07-03

4. Exosomes based strategies for cardiovascular diseases: Opportunities and challenges;Biomaterials;2024-07

5. Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction;European Heart Journal;2024-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3